Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis

Cell Immunol. 1996 Oct 10;173(1):149-54. doi: 10.1006/cimm.1996.0260.

Abstract

CD40--CD40L interactions between resting B cells and activated T cells are essential for germinal center formation. It has been shown that CD40L can induce both Fas expression and susceptibility to Fas-mediated killing in B cells, while anti-Ig can partially rescue B cells from Fas-mediated killing. However, the intracellular mechanism for this phenomenon is not known. We examined the expression of Fas and bcl-2 family gene products, such as Bcl-2, Bcl-x, Bax, and Mcl-1, in human tonsillar B cells. The activation of naive B cells by CD40L induced transient expression of Bcl-xL. As the Bcl-xL level decreased in CD40-activated B cells, the cells became susceptible to apoptosis by anti-Fas antibodies. Though anti-Ig did not change the Fas expression, it protected CD40-activated B cells from Fas-mediated killing by up-regulating Bcl-xL expression. The addition of anti-Ig did not significantly change Bcl-2, Bax, and Mcl-1 levels compared to those of B cells activated by CD40L alone.

MeSH terms

  • Apoptosis / immunology*
  • B-Lymphocytes / cytology
  • B-Lymphocytes / immunology*
  • CD40 Antigens / immunology*
  • CD40 Ligand
  • Cells, Cultured
  • Humans
  • Membrane Glycoproteins / immunology*
  • Proto-Oncogene Proteins / immunology*
  • Proto-Oncogene Proteins c-bcl-2*
  • Up-Regulation
  • bcl-X Protein
  • fas Receptor / immunology*

Substances

  • BCL2L1 protein, human
  • CD40 Antigens
  • Membrane Glycoproteins
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • bcl-X Protein
  • fas Receptor
  • CD40 Ligand